nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A survey of yeast genomic assays for drug and target discovery
|
Smith, Andrew M. |
|
2010 |
127 |
2 |
p. 156-164 9 p. |
artikel |
2 |
Cardiovascular risk factors regulate the expression of vascular endothelin receptors
|
Xu, Cang-Bao |
|
2010 |
127 |
2 |
p. 148-155 8 p. |
artikel |
3 |
Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?
|
Geisler, Tobias |
|
2010 |
127 |
2 |
p. 95-107 13 p. |
artikel |
4 |
ORAI-mediated calcium entry: Mechanism and roles, diseases and pharmacology
|
Roberts-Thomson, Sarah J. |
|
2010 |
127 |
2 |
p. 121-130 10 p. |
artikel |
5 |
Recent therapeutic approaches to platelet activation in coronary artery disease
|
Tousoulis, Dimitris |
|
2010 |
127 |
2 |
p. 108-120 13 p. |
artikel |
6 |
The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations
|
Tallarida, Ronald J. |
|
2010 |
127 |
2 |
p. 165-174 10 p. |
artikel |
7 |
Therapeutic advances in myocardial microvascular resistance: Unravelling the enigma
|
Patel, Billal |
|
2010 |
127 |
2 |
p. 131-147 17 p. |
artikel |
8 |
Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists
|
Dufton, Neil |
|
2010 |
127 |
2 |
p. 175-188 14 p. |
artikel |